公开(公告)号：US12295967B2

公开(公告)日：2025-05-13

申请号：US17051117

申请日：2019-04-24

Applicant: LEMONEX INC. ,  SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION

Inventor： Cheol Hee Won ,  Dal Hee Min

IPC: A61K31/7036 ,  A61K31/282 ,  A61K31/47 ,  A61K31/4706 ,  A61K31/496 ,  A61K31/536 ,  A61K31/5415 ,  A61K31/546 ,  A61K31/661 ,  A61K31/7048 ,  A61K38/12 ,  A61K38/14 ,  A61P31/14

Abstract: A method for treating a flavivirus infection includes administering to a subject in need thereof a composition which includes at least one of gentamicin sulfate, netilmicin, tobramycin, paromomycin, amikacin, capreomycin, trifluoperazine, dihydrostreptomycin, hydroxychloroquine, thioridazine HCl, efavirenz, miltefosine, nystatin, micafungin, bleomycin, resminostat, montelukast, norfloxacin, nedaplatin and cephalothin, which can exhibit excellent growth inhibition or killing effects of various species of flavivirus genus.